Stocks to Watch: These 12 stocks will be in focus on Wednesday, November 19, big movement can be seen – stocks to watch 19 November tcs hul infosys mgl nsdl escorts kubota azad engineering gr infra and more

Stocks to Watch: On Wednesday, November 19, investors will keep an eye on the shares of many companies. Big corporate updates related to these have come out. Important announcements have been made from companies in IT, FMCG, Gas, Engineering and Financial sectors. From TCS’s new partnership to Infosys’ buyback and HUL’s demerger, many news will be in the eye of investors.

TCS, the Tata Group’s leading IT company, has announced a 5-year partnership with the NHS supply chain. Under this deal, the company will improve the capacity and efficiency of Britain’s healthcare system with AI-based solutions.

FMCG company HUL has set December 5, 2025 as the record date for the demerger of its ice cream business. Based on this date, shareholders will receive shares of Kwality Wall’s (India) Ltd. The company said that the demerger scheme will become effective from December 1, 2025.

Hindustan Unilever Limited (HUL) has appointed Bobby Parikh as independent director with effect from December 1, 2025. He has previously been the CEO of Ernst & Young India. His five-year appointment will be subject to shareholder approval.

Giant company Infosys has said that its share buyback worth ₹18,000 crore will open on November 20 and close on November 26. The buyback will be done through tender offer route.

MGL said gas supply has been restored at its City Gate station in Wadala. GAIL completed repairs of the damaged pipeline within the RCF Trombay complex. Now supply has resumed at the affected CNG stations of Mumbai, Thane and Navi Mumbai.

Choice International’s subsidiary has purchased 100% stake in Ayoleeza Consultants. The company’s live orders have increased by more than ₹200 crore following the acquisition.

Goel Construction has received a new order worth ₹173 crore from Aditya Birla Group. This order is related to civil work in Pali Cement Works Unit.

The board of Nucleus Software has approved the reappointment of Parag Bhise as CEO. His new tenure will be effective for two years.

Agricultural equipment maker Escorts Kubota has launched its third generation ride-on rice transplanters in India. The company says that this technology will make paddy transplantation faster and more efficient.

Azad Engineering has entered into a significant agreement with Pratt & Whitney Canada Corp for the manufacturing and development of aircraft engine components.

GR Infra has got a new project worth ₹262 crore from Western Railways. This includes construction work related to rail infrastructure.

NSDL has been issued a warning letter by SEBI for non-compliance of disclosure rules. The regulator has asked the company to strictly ensure compliance standards.

Nifty Outlook: How will be the movement of Nifty on November 19, which levels will be important? Know from the expert

Disclaimer: The information provided here is being given for information only. It is important to mention here that investing in the market is subject to market risks. As an investor, always consult an expert before investing money. Moneycontrol never advises anyone to invest money here.

Source link

Mahamaya Lifesciences IPO Listing: Upper circuit as soon as listing, shares became rocket at ₹ 114 after sluggish entry – mahamaya lifesciences ipo listing shares debut over 1 percent premium mahamaya share price jumps further

Mahamaya Lifesciences IPO Listing: Shares of Mahamaya Sciences had a lackluster entry in the domestic market today. Its IPO received an overall bid of 1.63 times. Shares have been issued under the IPO at a price of ₹ 114.00. Today it has entered BSE SME at ₹ 116.00, which means IPO investors got a listing gain of 1.75% (Mahamaya Lifesciences Listing Gain). However, the joy of IPO investors soon faded as the shares crashed. After listing the shares went up further. It jumped and reached the upper circuit of ₹ 121.80 (Mahamaya Lifesciences Share Price) i.e. IPO investors are now in 6.84% profit.

How will Mahamaya Lifesciences IPO money be spent?

Mahamaya Lifesciences’ ₹70.44 crore IPO was open for subscription from November 11-13. This IPO received 1.63 times bids from investors. In this, the portion reserved for Qualified Institutional Buyers (QIB) was 1.19 times (ex-anchor), the portion for Non-Institutional Investors (NII) was 3.63 times and the portion for retail investors was 1.02 times. New shares worth ₹64.28 crore have been issued under this IPO. Apart from this, 5.40 lakh shares with face value of ₹ 10 have been sold under the offer for sale window.

The shareholders who sold the shares have received the money from the offer for sale. Of the money raised through new shares, ₹3.75 crore will be spent on purchase of equipment for the existing formulation plant, ₹29.42 crore will be spent on setup of new technical manufacturing plant, ₹2.53 crore will be spent on construction of warehouse building and purchase of machinery, ₹18.00 crore will be spent on working capital needs and the remaining money will be spent on general corporate purposes.

About Mahamaya Lifesciences

Mahamaya Lifesciences, established in the year 2002, manufactures formulas related to crop protection and soil health. It manufactures and supplies pesticides formulations in bulk to domestic and multinational companies. It imports researched molecules from abroad, then registers them with the Central Insecticides Board. After this, the company sells these to domestic and multinational companies in the form of technical and value-added formulations.

Talking about the financial health of the company, it has continuously strengthened. It had a net profit of ₹3.75 crore in FY 2023, which jumped to ₹5.22 crore in the next FY 2024 and ₹12.94 crore in FY 2025. During this period, the total income of the company increased at a compound growth rate (CAGR) of more than 39% annually to ₹ 267.17 crore. Talking about the current financial year 2026, in the first quarter April-June 2025, the company has achieved net profit of ₹ 4.10 crore and total income of ₹ 84.04 crore. At the end of June 2025 quarter, the company had a total debt of ₹57.72 crore while reserves and surplus were ₹35.73 crore.

Disclaimer: The information provided here is being provided for information only. It is important to mention here that investing in the market is subject to market risks. As an investor, always consult an expert before investing money. Moneycontrol never advises anyone to invest money here.

Source link

Stock market rally is coming! – stock markets is ready to fly high after nda gets trumping majority in bihar assembly watch video to know more

markets

This report of Motilal Oswal came before the stock market opened on 17 November. The results of Bihar assembly elections came on November 14, a day when there was a lot of volatility in the stock market. However, later the major indices of the market closed in the green. There was a rise in the stock market even on 17th November.

Source link

Is the bubble of AI stocks about to burst? Now this veteran investor sells entire stake in Nvidia – peter thiel hedge fund sells entire nvidia stake worth 100 million dollars in q3

After the tremendous rise in Artificial Intelligence (AI) stocks, the fears of the bubble bursting seem to be increasing. Meanwhile, big news has come that Thiel Macro LLC, the hedge fund company of American billionaire and tech investor Peter Thiel, sold its entire stake in Nvidia during the September quarter.

Thill Macro has sold all the 5,37,742 shares of Nvidia he holds. According to the closing price of September 30, their value is around 100 million dollars (about Rs 830 crore). After this selloff, Thill Macro’s biggest bet is now on the shares of Apple, Microsoft and Tesla.

Growing concern about AI bubble

Veteran hedge fund manager Michael Burry has also bet against AI companies like Nvidia and Palantir. “Sometimes we see bubbles,” he wrote in a recent post. Michael Burry is best known for correctly identifying the housing crash of 2008, which led to the global recession.

SoftBank also exited Nvidia

Japan’s leading investment firm SoftBank Group also sold its stake in Nvidia in October for about $5.83 billion. This fund was used to raise funds for other AI investments.

However, Peter Thill has never been as bullish on AI as SoftBank founder Masayoshi Son. But both investors have sold their stakes around Nvidia’s $5 trillion valuation level.

Hedge funds’ opinions divided

However, the opinion of the rest of the Fed Funds seems to be mixed. During the month of September, 161 out of 909 hedge funds increased investments in Nvidia. And 160 firms reduced investment. That means the market opinion is currently divided on this stock. AI companies are still raising funds vigorously, spending money rapidly, but their clear monetization models do not appear to be as strong.

Disclaimer: The views and investment advice given by experts/brokerage firms on Moneycontrol are their own and not those of the website and its management. Moneycontrol advises users to consult certified experts before taking any investment decision.

Source link